体外診断用医薬品包装市場：製品別、エンドユーザー別-2025-2030年の世界予測

体外診断用医薬品包装市場の2023年の市場規模は72億4,000万米ドルで、2024年には77億米ドルに達すると予測され、CAGR 6.75%で成長し、2030年には114億4,000万米ドルに達すると予測されています。

体外診断（IVD）包装市場は、健康状態の診断とモニタリングに使用される試薬、器具、検査キットなど、体外診断分野の製品に必要な特殊な包装ソリューションを指します。範囲と定義は、バイアル、チューブ、ボトル、クロージャーなど、診断用成分の安全性、安定性、無菌性を確保するための包装タイプをカバーしています。堅牢なIVD包装の必要性は、製品の完全性を保証し、汚染を防止し、温度に敏感な診断薬を輸送する複雑な物流ニーズに対応する厳しい規制基準によってもたらされます。用途別では、これらの包装ソリューションは病院、検査室、診療所で極めて重要であり、最終用途は病理検査室、研究機関、学術部門に及んでいます。主な成長要因としては、慢性疾患や感染症の流行、ポイントオブケア検査に対する需要の高まり、個別化医療の進展などが挙げられます。持続可能で環境に優しい包装材料へのシフトや、製品の追跡やユーザー関与を強化するスマート包装のような革新的ソリューションへの需要の高まりなど、ビジネスチャンスは豊富にあります。しかし、革新的な包装技術に関連する厳しい規制要件と高コストは、大きな市場課題となっています。さらに、世界中のヘルスケアシステムで価格圧力が高まり続けているため、費用対効果の高いパッケージングソリューションの必要性は依然として重要な制約となっています。技術革新の可能性のある分野としては、サプライチェーンの効率向上のためのIoTやRFID技術を組み込んだインテリジェント包装の開発、改ざん防止機能の強化、世界の持続可能性目標に沿った材料のリサイクル性や生分解性の向上などが挙げられます。このダイナミックな市場で成功するためには、プレーヤーは戦略的提携と継続的な研究開発に注力し、体外診断用医薬品業界の進化するニーズに合わせた、適応性とコンプライアンスに優れたパッケージング・ソリューションを提供する必要があります。綿密な市場調査を実施することで、競合考察を得ることができ、顧客の嗜好や技術の進歩を常に把握し、イノベーション主導でありながら規制の厳しい市場の特性に対応することができます。

市場力学：急速に進化する体外診断用医薬品包装市場の主要市場インサイトを公開

体外診断用医薬品包装市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患および感染症の蔓延
  • ポイントオブケア検査の動向の高まり
  • 個別化医療への傾斜
• 市場抑制要因
  • 体外診断用医薬品パッケージの製造コストの高さ
• 市場機会
  • 体外診断用スマート包装のイントロダクション
  • 持続可能な体外診断用包装の製造のための継続的な研究開発
• 市場の課題
  • 体外診断用医薬品の包装設計の複雑さ

ポーターの5つの力：体外診断用医薬品包装市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：体外診断用医薬品包装市場における外部からの影響の把握

外部マクロ環境要因は、体外診断用医薬品包装市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析体外診断用医薬品包装市場における競合情勢の把握

体外診断用医薬品包装市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス体外診断用医薬品包装市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、体外診断用医薬品包装市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨体外診断用医薬品包装市場における成功への道筋を描く

体外診断用医薬品包装市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患および感染症の蔓延の増加
    • ポイントオブケア検査の増加傾向
    • 個別化医療へのアプローチへの傾向
  • 抑制要因
    • 体外診断用パッケージの生産コストが高い
  • 機会
    • 体外診断用スマートパッケージのイントロダクション
    • 持続可能な体外診断用パッケージの製造に向けた継続的な研究開発
  • 課題
    • 体外診断用パッケージの設計の複雑さ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 体外診断用医薬品包装市場：製品別

• ボトル
• 閉鎖
• チューブ
• バイアル

第7章 体外診断用医薬品包装市場：エンドユーザー別

• 学術機関
• 臨床検査室
• 病院

第8章 南北アメリカの体外診断用医薬品包装市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の体外診断用医薬品包装市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの体外診断用医薬品包装市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Amcor PLC
• APTARGROUP, INC.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Corning Incorporated
• DWK Life Sciences GmbH
• DWK Life Sciences LLC
• James Alexander Corporation
• Narang Medical Limited
• Oliver-Tolas Healthcare Packaging B.V.
• PerkinElmer Inc.
• PMMI Media Group
• QIAGEN N.V.
• Siemens AG
• SONIC PACKAGING
• Thermofisher Scientific Inc.
• VITLAB GmbH

LIST OF FIGURES

• FIGURE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET RESEARCH PROCESS
• FIGURE 2. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. IN-VITRO DIAGNOSTICS PACKAGING MARKET DYNAMICS
• TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLOSURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

The In-Vitro Diagnostics Packaging Market was valued at USD 7.24 billion in 2023, expected to reach USD 7.70 billion in 2024, and is projected to grow at a CAGR of 6.75%, to USD 11.44 billion by 2030.

The In-Vitro Diagnostics (IVD) Packaging market refers to the specialized packaging solutions required for products in the in-vitro diagnostics sector, including reagents, instruments, and testing kits used in the diagnosis and monitoring of health conditions. Scope and definition cover packaging types such as vials, tubes, bottles, and closures that ensure the safety, stability, and sterility of diagnostic components. The necessity for robust IVD packaging is driven by the strict regulatory standards ensuring product integrity, preventing contamination, and addressing the complex logistics needs of transporting temperature-sensitive diagnostics. Application-wise, these packaging solutions are pivotal across hospitals, laboratories, and clinics, while the end-use scope spans pathology labs, research institutes, and academic sectors. Key growth influencers include the increasing prevalence of chronic and infectious diseases, escalated demand for point-of-care testing, and advancements in personalized medicine. Opportunities abound with the shift toward sustainable and eco-friendly packaging materials, and increased demand for innovative solutions like smart packaging that enhances product tracking and user engagement. However, stringent regulatory requirements and high costs associated with innovative packaging technologies pose significant market challenges. Furthermore, the need for cost-effective packaging solutions remains a critical limitation as pricing pressures continue to rise across healthcare systems globally. Potential areas of innovation include developing intelligent packaging that incorporates IoT and RFID technologies for improved supply chain efficiency, enhancing tamper-evidence features, and increasing the recyclability and biodegradability of materials to align with global sustainability goals. To thrive in this dynamic market, players should focus on strategic collaborations and continuous R&D to offer adaptable and compliant packaging solutions tailored to the evolving needs of the IVD industry. Conducting in-depth market research would yield competitive insights and keep businesses abreast of customer preferences and technological advancements, addressing the nature of the market that is innovation-driven but heavily regulated.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Diagnostics Packaging Market

The In-Vitro Diagnostics Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of chronic and infectious diseases
  • Rising trend of point-of-care testing
  • Inclination toward personalized medicine approach
• Market Restraints
  • High cost of production of in-vitro diagnostic packaging
• Market Opportunities
  • Introduction of smart packaging for in-vitro diagnostics
  • Ongoing R&D for the production of sustainable in-vitro diagnostic packaging
• Market Challenges
  • Complexity in designing in-vitro diagnostic packaging

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Diagnostics Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Diagnostics Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Diagnostics Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Diagnostics Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Diagnostics Packaging Market

A detailed market share analysis in the In-Vitro Diagnostics Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Diagnostics Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Diagnostics Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Diagnostics Packaging Market

A strategic analysis of the In-Vitro Diagnostics Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Diagnostics Packaging Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, APTARGROUP, INC., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, DWK Life Sciences GmbH, DWK Life Sciences LLC, James Alexander Corporation, Narang Medical Limited, Oliver-Tolas Healthcare Packaging B.V., PerkinElmer Inc., PMMI Media Group, QIAGEN N.V., Siemens AG, SONIC PACKAGING, Thermofisher Scientific Inc., and VITLAB GmbH.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Diagnostics Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Bottles, Closures, Tubes, and Vials.
• Based on End User, market is studied across Academic Institutes, Clinical Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic and infectious diseases
    • 5.1.1.2. Rising trend of point-of-care testing
    • 5.1.1.3. Inclination toward personalized medicine approach
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of production of in-vitro diagnostic packaging
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of smart packaging for in-vitro diagnostics
    • 5.1.3.2. Ongoing R&D for the production of sustainable in-vitro diagnostic packaging
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity in designing in-vitro diagnostic packaging
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. In-Vitro Diagnostics Packaging Market, by Product

• 6.1. Introduction
• 6.2. Bottles
• 6.3. Closures
• 6.4. Tubes
• 6.5. Vials

7. In-Vitro Diagnostics Packaging Market, by End User

• 7.1. Introduction
• 7.2. Academic Institutes
• 7.3. Clinical Laboratories
• 7.4. Hospitals

8. Americas In-Vitro Diagnostics Packaging Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific In-Vitro Diagnostics Packaging Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa In-Vitro Diagnostics Packaging Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amcor PLC
• 2. APTARGROUP, INC.
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. Corning Incorporated
• 6. DWK Life Sciences GmbH
• 7. DWK Life Sciences LLC
• 8. James Alexander Corporation
• 9. Narang Medical Limited
• 10. Oliver-Tolas Healthcare Packaging B.V.
• 11. PerkinElmer Inc.
• 12. PMMI Media Group
• 13. QIAGEN N.V.
• 14. Siemens AG
• 15. SONIC PACKAGING
• 16. Thermofisher Scientific Inc.
• 17. VITLAB GmbH